11709566

Source:http://linkedlifedata.com/resource/pubmed/id/11709566

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006142, umls-concept:C0006826, umls-concept:C0008976, umls-concept:C0029246, umls-concept:C0035168, umls-concept:C0087111, umls-concept:C0205225, umls-concept:C0239307, umls-concept:C1274040, umls-concept:C2347669
pubmed:issue	22
pubmed:dateCreated	2001-11-15
pubmed:abstractText	To evaluate whether preoperative neoadjuvant chemotherapy in patients with primary operable breast cancer results in better overall survival (OS) and relapse-free survival rates and whether preoperative chemotherapy permits more breast-conserving surgery procedures than postoperative chemotherapy.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/11709566-12065569
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Epirubicin, http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	0732-183X
pubmed:author	pubmed-author:DuchateauLL, pubmed-author:JulienJ PJP, pubmed-author:Tubiana-HulinMM, pubmed-author:VanderveldenCC, pubmed-author:van de VeldeC JCJ, pubmed-author:van der HageJ AJA
pubmed:issnType	Print
pubmed:day	15
pubmed:volume	19
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	4224-37
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:11709566-Aged, pubmed-meshheading:11709566-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:11709566-Breast Neoplasms, pubmed-meshheading:11709566-Cyclophosphamide, pubmed-meshheading:11709566-Disease-Free Survival, pubmed-meshheading:11709566-Epirubicin, pubmed-meshheading:11709566-Female, pubmed-meshheading:11709566-Fluorouracil, pubmed-meshheading:11709566-Humans, pubmed-meshheading:11709566-Mastectomy, Radical, pubmed-meshheading:11709566-Mastectomy, Segmental, pubmed-meshheading:11709566-Middle Aged, pubmed-meshheading:11709566-Neoadjuvant Therapy, pubmed-meshheading:11709566-Neoplasm Recurrence, Local, pubmed-meshheading:11709566-Neoplasm Staging, pubmed-meshheading:11709566-Preoperative Care, pubmed-meshheading:11709566-Quality of Life, pubmed-meshheading:11709566-Receptors, Estrogen, pubmed-meshheading:11709566-Survival Rate
pubmed:year	2001
pubmed:articleTitle	Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902.
pubmed:affiliation	European Organization for Research and Treatment of Cancer Data Center, Brussels, Belgium. velde@lumc.nl
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Clinical Trial, Phase III